The Potency of Nef-Mediated SERINC5 Antagonism Correlates with the Prevalence of Primate Lentiviruses in the Wild

Cell Host and Microbe

Volumn 20, Issue 3, 2016, Pages 381-391

  Heigele, Anke ^a   Kmiec, Dorota ^a   Regensburger, Kerstin ^a   Langer, Simon ^a   Peiffer, Lukas ^a   Stürzel, Christina M ^a   Sauter, Daniel ^a   Peeters, Martine ^b   Pizzato, Massimo ^c   Learn, Gerald H ^d   Hahn, Beatrice H ^d   Kirchhoff, Frank ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^c UNIVERSITY OF TRENTO   (Italy)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR FACTOR SERINE INCORPORATOR 5; MEMBRANE PROTEIN; NEF PROTEIN; UNCLASSIFIED DRUG; NEF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; NEF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 2; NEF PROTEIN, SIV; VIRAL PROTEIN; VIRULENCE FACTOR;

APE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHIMPANZEE; COLOBUS; CONTROLLED STUDY; HAPLORHINI; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2; LENTIVIRINAE; NONHUMAN; PREVALENCE; PRIMATE; PRIORITY JOURNAL; PROTEIN MOTIF; VIRUS INFECTIVITY; VIRUS TRANSMISSION; WILD ANIMAL; ANIMAL; CELL CULTURE; IMMUNOLOGY; METABOLISM; MOUSE; PATHOGENICITY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TRANSMISSION; VIROLOGY;

ANIMALS; CELLS, CULTURED; HIV-1; HIV-2; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PRIMATES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRULENCE FACTORS;

EID: 84995543461     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2016.08.004     Document Type: Article

References (51)

1. Aiken, C., Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J. Virol. 71 (1997), 5871–5877.
2. Argañaraz, E.R., Schindler, M., Kirchhoff, F., Cortes, M.J., Lama, J., Enhanced CD4 down-modulation by late stage HIV-1 nef alleles is associated with increased Env incorporation and viral replication. J. Biol. Chem. 278 (2003), 33912–33919.
3. Arhel, N.J., Kirchhoff, F., Implications of Nef: host cell interactions in viral persistence and progression to AIDS. Curr. Top. Microbiol. Immunol. 339 (2009), 147–175.
4. Bailes, E., Gao, F., Bibollet-Ruche, F., Courgnaud, V., Peeters, M., Marx, P.A., Hahn, B.H., Sharp, P.M., Hybrid origin of SIV in chimpanzees. Science, 300, 2003, 1713.
5. Campbell, E.M., Nunez, R., Hope, T.J., Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity. J. Virol. 78 (2004), 5745–5755.
6. Campbell-Yesufu, O.T., Gandhi, R.T., Update on human immunodeficiency virus (HIV)-2 infection. Clin. Infect. Dis. 52 (2011), 780–787.
7. Carl, S., Greenough, T.C., Krumbiegel, M., Greenberg, M., Skowronski, J., Sullivan, J.L., Kirchhoff, F., Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS. J. Virol. 75 (2001), 3657–3665.
8. Chowers, M.Y., Spina, C.A., Kwoh, T.J., Fitch, N.J., Richman, D.D., Guatelli, J.C., Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J. Virol. 68 (1994), 2906–2914.
9. D'arc, M., Ayouba, A., Esteban, A., Learn, G.H., Boué, V., Liegeois, F., Etienne, L., Tagg, N., Leendertz, F.H., Boesch, C., et al. Origin of the HIV-1 group O epidemic in western lowland gorillas. Proc. Natl. Acad. Sci. U S A 112 (2015), E1343–E1352.
10. Deacon, N.J., Tsykin, A., Solomon, A., Smith, K., Ludford-Menting, M., Hooker, D.J., McPhee, D.A., Greenway, A.L., Ellett, A., Chatfield, C., et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270 (1995), 988–991.
11. Felsenstein, J., Phylogenies and the comparative method. Am. Nat. 125 (1985), 1–15.
12. Garland, T. Jr., Harvey, P.H., Ives, A.R., Procedures for the analysis of comparative data using phylogenetically independent contrasts. Syst. Biol. 41 (1992), 18–32.
13. Greenberg, M.E., Bronson, S., Lock, M., Neumann, M., Pavlakis, G.N., Skowronski, J., Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation. EMBO J. 16 (1997), 6964–6976.
14. Haller, C., Müller, B., Fritz, J.V., Lamas-Murua, M., Stolp, B., Pujol, F.M., Keppler, O.T., Fackler, O.T., HIV-1 Nef and Vpu are functionally redundant broad-spectrum modulators of cell surface receptors, including tetraspanins. J. Virol. 88 (2014), 14241–14257.
15. Heigele, A., Schindler, M., Gnanadurai, C.W., Leonard, J.A., Collins, K.L., Kirchhoff, F., Down-modulation of CD8αβ is a fundamental activity of primate lentiviral Nef proteins. J. Virol. 86 (2012), 36–48.
16. Jia, B., Serra-Moreno, R., Neidermyer, W., Rahmberg, A., Mackey, J., Fofana, I.B., Johnson, W.E., Westmoreland, S., Evans, D.T., Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog., 5, 2009, e1000429.
17. Keele, B.F., Van Heuverswyn, F., Li, Y., Bailes, E., Takehisa, J., Santiago, M.L., Bibollet-Ruche, F., Chen, Y., Wain, L.V., Liegeois, F., et al. Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science 313 (2006), 523–526.
18. Kestler, H.W. 3rd, Ringler, D.J., Mori, K., Panicali, D.L., Sehgal, P.K., Daniel, M.D., Desrosiers, R.C., Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65 (1991), 651–662.
19. Kirchhoff, F., Greenough, T.C., Brettler, D.B., Sullivan, J.L., Desrosiers, R.C., Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332 (1995), 228–232.
20. Kluge, S.F., Mack, K., Iyer, S.S., Pujol, F.M., Heigele, A., Learn, G.H., Usmani, S.M., Sauter, D., Joas, S., Hotter, D., et al. Nef proteins of epidemic HIV-1 group O strains antagonize human tetherin. Cell Host Microbe 16 (2014), 639–650.
21. Lama, J., Mangasarian, A., Trono, D., Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner. Curr. Biol. 9 (1999), 622–631.
22. Li, Y., Ndjango, J.B., Learn, G.H., Ramirez, M.A., Keele, B.F., Bibollet-Ruche, F., Liu, W., Easlick, J.L., Decker, J.M., Rudicell, R.S., et al. Eastern chimpanzees, but not bonobos, represent a simian immunodeficiency virus reservoir. J. Virol. 86 (2012), 10776–10791.
23. Miller, M.D., Warmerdam, M.T., Gaston, I., Greene, W.C., Feinberg, M.B., The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179 (1994), 101–113.
24. Münch, J., Schindler, M., Wildum, S., Rücker, E., Bailer, N., Knoop, V., Novembre, F.J., Kirchhoff, F., Primary sooty mangabey simian immunodeficiency virus and human immunodeficiency virus type 2 nef alleles modulate cell surface expression of various human receptors and enhance viral infectivity and replication. J. Virol. 79 (2005), 10547–10560.
25. Münch, J., Rajan, D., Schindler, M., Specht, A., Rücker, E., Novembre, F.J., Nerrienet, E., Müller-Trutwin, M.C., Peeters, M., Hahn, B.H., Kirchhoff, F., Nef-mediated enhancement of virion infectivity and stimulation of viral replication are fundamental properties of primate lentiviruses. J. Virol. 81 (2007), 13852–13864.
26. Ochsenbauer, C., Edmonds, T.G., Ding, H., Keele, B.F., Decker, J., Salazar, M.G., Salazar-Gonzalez, J.F., Shattock, R., Haynes, B.F., Shaw, G.M., et al. Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages. J. Virol. 86 (2012), 2715–2728.
27. Paradis, E., Claude, J., Strimmer, K., APE: Analyses of Phylogenetics and Evolution in R language. Bioinformatics 20 (2004), 289–290.
28. Pawlak, E.N., Dikeakos, J.D., HIV-1 Nef: a master manipulator of the membrane trafficking machinery mediating immune evasion. Biochim. Biophys. Acta 1850 (2015), 733–741.
29. Pizzato, M., MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1. Proc. Natl. Acad. Sci. U S A 107 (2010), 9364–9369.
30. Pyndiah, N., Telenti, A., Rausell, A., Evolutionary genomics and HIV restriction factors. Curr. Opin. HIV AIDS 10 (2015), 79–83.
31. Qi, M., Aiken, C., Selective restriction of Nef-defective human immunodeficiency virus type 1 by a proteasome-dependent mechanism. J. Virol. 81 (2007), 1534–1536.
32. Ren, X., Park, S.Y., Bonifacino, J.S., Hurley, J.H., How HIV-1 Nef hijacks the AP-2 clathrin adaptor to downregulate CD4. eLife, 3, 2014, e01754.
33. Roeth, J.F., Collins, K.L., Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways. Microbiol. Mol. Biol. Rev. 70 (2006), 548–563.
34. Rosa, A., Chande, A., Ziglio, S., De Sanctis, V., Bertorelli, R., Goh, S.L., McCauley, S.M., Nowosielska, A., Antonarakis, S.E., Luban, J., et al. HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation. Nature 526 (2015), 212–217.
35. Sauter, D., Schindler, M., Specht, A., Landford, W.N., Münch, J., Kim, K.A., Votteler, J., Schubert, U., Bibollet-Ruche, F., Keele, B.F., et al. Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe 6 (2009), 409–421.
36. Sauter, D., Specht, A., Kirchhoff, F., Tetherin: holding on and letting go. Cell 141 (2010), 392–398.
37. Sauter, D., Hué, S., Petit, S.J., Plantier, J.-C., Towers, G.J., Kirchhoff, F., Gupta, R.K., HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef. Retrovirology, 8, 2011, 103.
38. Sauter, D., Unterweger, D., Vogl, M., Usmani, S.M., Heigele, A., Kluge, S.F., Hermkes, E., Moll, M., Barker, E., Peeters, M., et al. Human tetherin exerts strong selection pressure on the HIV-1 group N Vpu protein. PLoS Pathog., 8, 2012, e1003093.
39. Sauter, D., Hotter, D., Van Driessche, B., Stürzel, C.M., Kluge, S.F., Wildum, S., Yu, H., Baumann, B., Wirth, T., Plantier, J.C., et al. Differential regulation of NF-κB-mediated proviral and antiviral host gene expression by primate lentiviral Nef and Vpu proteins. Cell Rep. 10 (2015), 586–599.
40. Schindler, M., Münch, J., Kutsch, O., Li, H., Santiago, M.L., Bibollet-Ruche, F., Müller-Trutwin, M.C., Novembre, F.J., Peeters, M., Courgnaud, V., et al. Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125 (2006), 1055–1067.
41. Schmökel, J., Li, H., Bailes, E., Schindler, M., Silvestri, G., Hahn, B.H., Apetrei, C., Kirchhoff, F., Conservation of Nef function across highly diverse lineages of SIVsmm. Retrovirology, 6, 2009, 36.
42. Schmökel, J., Sauter, D., Schindler, M., Leendertz, F.H., Bailes, E., Dazza, M.C., Saragosti, S., Bibollet-Ruche, F., Peeters, M., Hahn, B.H., Kirchhoff, F., The presence of a vpu gene and the lack of Nef-mediated downmodulation of T cell receptor-CD3 are not always linked in primate lentiviruses. J. Virol. 85 (2011), 742–752.
43. Sharp, P.M., Hahn, B.H., Origins of HIV and the AIDS pandemic. Cold Spring Harb. Perspect. Med., 1, 2011, a006841.
44. Ueno, F., Shiota, H., Miyaura, M., Yoshida, A., Sakurai, A., Tatsuki, J., Koyama, A.H., Akari, H., Adachi, A., Fujita, M., Vpx and Vpr proteins of HIV-2 up-regulate the viral infectivity by a distinct mechanism in lymphocytic cells. Microbes Infect. 5 (2003), 387–395.
45. Usami, Y., Göttlinger, H., HIV-1 Nef responsiveness is determined by Env variable regions involved in trimer association and correlates with neutralization sensitivity. Cell Rep. 5 (2013), 802–812.
46. Usami, Y., Wu, Y., Göttlinger, H.G., SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef. Nature 526 (2015), 218–223.
47. Van Heuverswyn, F., Li, Y., Bailes, E., Neel, C., Lafay, B., Keele, B.F., Shaw, K.S., Takehisa, J., Kraus, M.H., Loul, S., et al. Genetic diversity and phylogeographic clustering of SIVcpzPtt in wild chimpanzees in Cameroon. Virology 368 (2007), 155–171.
48. Wildum, S., Schindler, M., Münch, J., Kirchhoff, F., Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection. J. Virol. 80 (2006), 8047–8059.
49. Yang, S.J., Lopez, L.A., Exline, C.M., Haworth, K.G., Cannon, P.M., Lack of adaptation to human tetherin in HIV-1 group O and P. Retrovirology, 8, 2011, 78.
50. Zhang, F., Wilson, S.J., Landford, W.C., Virgen, B., Gregory, D., Johnson, M.C., Munch, J., Kirchhoff, F., Bieniasz, P.D., Hatziioannou, T., Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 6 (2009), 54–67.
51. Zheng, Y.H., Plemenitas, A., Fielding, C.J., Peterlin, B.M., Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions. Proc. Natl. Acad. Sci. U S A 100 (2003), 8460–8465.